BIBLIOGRAPHIC RECORD

A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (µ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Neil Singla; Harold S. Minkowitz; David G. Soergel; David A. Burt; Ruth Ann Subach; Monica Salamea; Michael J. Fossler; Franck G. Skobieranda
Source of metadata
OpenAlex
Year recorded
2017

Public identifiers and source

Open the source record

Reference

Neil Singla; Harold S. Minkowitz; David G. Soergel; David A. Burt; Ruth Ann Subach; Monica Salamea; Michael J. Fossler; Franck G. Skobieranda. (2017). A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (µ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty. https://openalex.org/W2761456602

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-1d4bf714a882568ba6292ff209976b3d/